Safety and Efficacy of Osimertinib in Patients With Non–Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis Patient ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Patients with type 2 and type 1 diabetes (T2D ...
Despite all these published in vitro, in vivo and even preliminary clinical studies showing desirable features of HDACIs as a potential therapeutic agent, so far, to the best of the authors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback